Skip to main content

Table 2 System suitability and system repeatability results

From: Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form

Parameters TLS RST Acceptance criteria
Retention time (min) 2.553 4.505
USP plate counts 2917 8288  > 2000
USP tailing factor 1.44 1.23 NMT 2.0
USP resolution 9.40 NLT 2.0
% RSD of five replicate injections of standard 1 1.67 1.52  ≤ 2.0%
The % RD between two standards 0.75 0.51  ≤ 2.0%